Application Sponsors
ANDA 211695 | AUROBINDO PHARMA LTD | |
Marketing Status
Application Products
001 | TABLET;ORAL | 250MG;250MG;65MG | 0 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-02-02 | STANDARD |
Submissions Property Types
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 211695
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ACETAMINOPHEN, ASPIRIN AND CAFFEINE","activeIngredients":"ACETAMINOPHEN; ASPIRIN; CAFFEINE","strength":"250MG;250MG;65MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"02\/02\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2022-02-02
)
)